ChemR23 prevents phenotypic switching of vascular smooth muscle cells into macrophage-like foam cells in atherosclerosis
Cardiovascular Research · 16.03.2026 · 122 (2) · 195-213
DOI: 10.1093/cvr/cvaf258 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 20.11.2025. Verfasst von Bryce R Evans und 23 weiteren Autor:innen. Beteiligte Einrichtung: Division of Angiology, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 20, 3010 Bern, Switzer…. Hauptthemen laut MEDLINE: Foam Cells, Muscle, Smooth, Vascular, Atherosclerosis, Myocytes, Smooth Muscle. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Swiss Heart Foundation, Novartis foundation, Swiss National Foundation.
Abstract (Originalsprache)
Aims
Haematopoietic ChemR23 deficiency was shown to reduce atherosclerotic lesions by increasing M2 macrophages, but conflicting results in systemically deficient mice suggest a cell-specific function of ChemR23. Therefore, we aimed to study the role of ChemR23 particularly on vascular smooth muscle cells (VSMCs) in atherosclerosis. Methods and results Mice with a non-haematopoietic cell ChemR23 deficiency due to bone marrow transplantation of apolipoprotein E deficient bone marrow into irradiated ChemR23e/e Apoe−/− double deficient recipient mice (Apoe−/− ►ChemR23e/e Apoe−/−) were fed a western diet (WD) for 6 or 12 weeks. Subsequent analysis revealed an increased lesion size and enhanced VSMC proliferation and VSMC foam cells in Apoe−/− ►ChemR23e/e Apoe−/− mice. Bulk RNA sequencing of adventitia-stripped aortas of Apoe−/− ►ChemR23e/e Apoe−/− mice exposed an increase in gene expression of synthetic VSMC markers such as Lgals3 and Cd68, while contractile genes were downregulated. Likewise, single-cell transcriptome data from advanced human atherosclerotic plaques uncovered the highest ChemR23 expression in contractile VSMCs, while its expression in synthetic VSMCs was markedly reduced. In vitro, treatment of human aortic smooth muscle cells (HASMCs) with α-N-ethyl-3-(4-(trifluoromethyl)phenyl)acetamide (α-NETA), a small molecule inhibitor of ChemR23, increased synthetic gene expression but downregulated expression of transforming growth factor beta (TGFB), ATP Binding Cassette Subfamily A Member 1, ATP binding cassette Subfamily G Member 1, and scavenger receptor Class B Type 1. Further, α-NETA–treated HASMCs downregulated TGFB secretion, increased cholesterol uptake but decreased cholesterol efflux, and showed enhanced cell proliferation. Agonizing ChemR23 with its bona fide ligand chemerin 9 (C9) had no effect on synthetic gene expression but mitigated the effects of α-NETA on gene expression, cholesterol uptake, efflux, and cell proliferation. In vivo, both α-NETA and C9 treatment of Apoe−/− mice over 4 weeks WD revealed therapeutic potential. C9 reduced general inflammatory burden, while α-NETA promoted an atheroprotective M2 macrophage phenotype.
Conclusion
These findings suggest a critical role of ChemR23 in regulating VSMC phenotype switching thereby affecting atherosclerosis and suggest ChemR23 as a therapeutic target to either modulate inflammation (C9) or macrophage polarization (α-N-ethyl-3-(4-(trifluoromethyl)phenyl)acetamide; α-NETA) in atherosclerotic disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Angiology, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 20, 3010 Bern, Switzerland.
- Department for BioMedical Research (DBMR), University of Bern, Murtenstrasse 28, 3008 Bern, Switzerland.
- Graduate School for Cellular and Biomedical Sciences, University of Bern, Mittelstrasse 43, 3012 Bern, Switzerland.
- Department of Vascular Surgery, Bern University Hospital, University of Bern, Freiburgstrasse 20, 3010 Bern, Switzerland.
- Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-University Munich (LMU), Pettenkoferstrasse 9, 80336 Munich, Germany.
- Heart Center and Shanghai Institute of Pediatric Congenital Heart Disease, Shanghai Children's Medical Center, National Children's Medical Center, Shanghai Jiao Tong University School of Medicine, No.1678, Dongfang Road…
ORCID-Profile: Alexander Bartelt, Lars Maegdefessel, Heidi Noels, Donato Santovito, Yvonne Döring
Förderung
- Swiss Heart Foundation
- Novartis foundation
- Swiss National Foundation
- National Natural Science Foundation of China
- Deutsche Forschungsgemeinschaft
- German Centre for Cardiovascular Research
- Interdisciplinary Center for Clinical Research
- RWTH Aachen University
Zitieren
APA
Evans, B. R., Schulz, J., Triantafyllidou, V., Yerly, A., Thakur, M., Angliker, N., Siegrist, M., Jansen, Y., Yan, Y., Maas, S. L., Gold, C., Farina, F. M., Bayer, B., Bartelt, A., Weber, C., Wettich, J., Maegdefessel, L., Sachs, N., Schindewolf, M., …, & Döring, Y. (2026). ChemR23 prevents phenotypic switching of vascular smooth muscle cells into macrophage-like foam cells in atherosclerosis. Cardiovascular Research, 122(2), 195-213. https://doi.org/10.1093/cvr/cvaf258
Vancouver
Evans BR, Schulz J, Triantafyllidou V, Yerly A, Thakur M, Angliker N, et al. ChemR23 prevents phenotypic switching of vascular smooth muscle cells into macrophage-like foam cells in atherosclerosis. Cardiovascular Research. 2026;122(2):195-213. doi:10.1093/cvr/cvaf258
BibTeX
@article{Evans2026,
author = {Evans, Bryce R and Schulz, Julia and Triantafyllidou, Vasiliki and Yerly, Anais and Thakur, Manovriti and Angliker, Nico and Siegrist, Mark and Jansen, Yvonne and Yan, Yi and Maas, Sanne L and Gold, Christoph and Farina, Floriana M and Bayer, Batoul and Bartelt, Alexander and Weber, Christian and Wettich, Justus and Maegdefessel, Lars and Sachs, Nadia and Schindewolf, Marc and Kotelis, Drosos and Noels, Heidi and Santovito, Donato and van der Vorst, Emiel P C and Döring, Yvonne},
title = {ChemR23 prevents phenotypic switching of vascular smooth muscle cells into macrophage-like foam cells in atherosclerosis},
journal = {Cardiovascular Research},
year = {2026},
volume = {122},
number = {2},
pages = {195--213},
doi = {10.1093/cvr/cvaf258}
}
EUVIMED